肉汤微量稀释
抗菌剂
最小抑制浓度
抗生素
生物
微生物学
医学
作者
Štefan Schwarz,A. Böttner,Hafez Mohamed Hafez,Corinna Kehrenberg,Manfred Kietzmann,Dieter Klarmann,Günter Klein,Peter Krabisch,Tilman Kühn,Gabriele Luhofer,Angelika Richter,Wolfgang Traeder,Karl-Heinz Waldmann,Jürgen Wallmann,Christiane Werckenthin
出处
期刊:PubMed
日期:2004-02-10
卷期号:116 (9-10): 353-61
被引量:13
摘要
In-vitro susceptibility testing provides valuable informations for choosing the most suitable antimicrobial agent for the control of bacterial infections in animals. Different diffusion and dilution methods, as conducted according to various approved performance standards, can be used to determine the in-vitro susceptibility of bacterial pathogens. In the present article, problems are discussed which arise from the use of different methods and the difficulty to interpret such results. While most approved performance standards were designed for testing of bacteria from human sources, the NCCLS document M31-A2 exclusively focusses on susceptibility testing of bacteria isolated from animals and--in contrast to all other standards--includes veterinary specific breakpoints for a number of antimicrobial agents used in veterinary medicine. Therefore, performance of in-vitro susceptibility testing of veterinary pathogens should follow the recommendations given in the NCCLS document M31-A2. The microdilution method is recommended as the method of choice for susceptibility testing. The result of a microdilution test is given as the minimum inhibitory concentration (MIC). This value provides a quantitative result which precisely indicates the degree of susceptibility of the tested bacterial strain and in return gives the veterinarian a clear guidance whether therapeutic intervention with the antibiotic in question will be successful.
科研通智能强力驱动
Strongly Powered by AbleSci AI